Linked from

The 15 pages that link to Bone mineral density, each with the reason it gives.

• OsteoporosisRelated: It is a major clinical measure of skeletal status, though it does not capture every aspect of bone strength.

• Bone remodelingRelated: The balance of remodeling formation and resorption affects measured density.

• PubertyRelated: Puberty is a key period for accumulating bone mass.

• Celiac diseaseRelated: Poor absorption of calcium and vitamin D can lower bone density in untreated disease.

• HypogonadismRelated: Prolonged sex-hormone deficiency can reduce bone density.

• PachyostosisRelated: It measures one aspect of the increased density associated with pachyostosis.

• Growth hormone deficiencyRelated: Adults with deficiency may have reduced bone mass, one aspect of its metabolic effects.

• Gender-affirming hormone therapyRelated: Prolonged suppression of sex hormones without adequate replacement can affect bone health.

• AmenorrheaRelated: Prolonged low estrogen associated with amenorrhea can reduce bone density.

• AromataseRelated: Reduced estrogen synthesis through aromatase inhibition can lower bone density.

• Glucocorticoid-induced osteoporosisRelated: Density can fall rapidly after treatment starts, but does not capture all fracture risk.

• Inhaled corticosteroidRelated: Long-term high-dose exposure may contribute to reduced bone density in some patients.

• Primary ovarian insufficiencyRelated: Long-term estrogen deficiency can reduce bone density, making assessment and prevention relevant.

• HyperparathyroidismRelated: Measurement can reveal skeletal effects of prolonged excess parathyroid hormone.

• Tenofovir disoproxilRelated: Tenofovir disoproxil can reduce bone mineral density, especially with sustained exposure.